Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,547,351
+$476,847 QoQ
Shares Held
10,123
+6.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,765
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIRST FOUNDATION ADVISORS holds $34,560,047 across 8 Drug Manufacturers - General names. ABBV ranks #6 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
47,126 | $11,968,589 | |
| 2 | LLY |
ELI LILLY & Co
|
5,869 | $7,039,455 | |
| 3 | AZN |
Astrazeneca PLC
|
18,550 | $3,517,450 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
24,720 | $3,123,124 | |
| 5 | PFE |
Pfizer Inc
|
121,118 | $2,916,521 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
10,123 | $2,547,351 | |
| 7 | MRK |
Merck & Co., Inc.
|
16,084 | $2,066,794 | |
| 8 | AMGN |
Amgen Inc
|
3,813 | $1,380,763 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,547,351 | 10,123 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,070,504 | 9,520 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $2,246,056 | 9,830 | Shares | Defined | 2026-02-04 | |
| 2025-09-30 | $2,268,165 | 9,796 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,832,626 | 9,873 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,726,654 | 8,241 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,583,661 | 8,912 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,757,373 | 8,899 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,665,458 | 9,710 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,796,597 | 9,866 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,411,155 | 9,106 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,244,544 | 15,058 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,882,043 | 13,969 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,075,953 | 13,026 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,885,342 | 11,666 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,584,214 | 11,804 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,776,349 | 11,598 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,157,035 | 13,306 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $1,622,498 | 11,983 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,252,047 | 11,607 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,249,628 | 11,094 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,063,369 | 9,826 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $1,132,146 | 10,566 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $901,914 | 10,297 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,034,915 | 10,541 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $586,891 | 7,703 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||